Satellos Bioscience Inc (QB) (MSCLF) Cours

Satellos is a biotechnology company dedicated to developing life-changing medicines to treat degenerative muscle conditions. Satellos' lead program is focused on developing an oral therapeutic drug intended to correct muscle stem cell polarity and restore the body's innate muscle repair and regenera... Satellos is a biotechnology company dedicated to developing life-changing medicines to treat degenerative muscle conditions. Satellos' lead program is focused on developing an oral therapeutic drug intended to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. This therapeutic approach represents a potential disease modifying treatment for Duchenne and other dystrophies, offering new hope to patients. To expand programs to other degenerative muscle conditions or disorders, Satellos has created a proprietary discovery platform, MyoReGenX, which is utilized to identify disease situations where deficits in muscle stem cell polarity and regeneration occur and are amenable to therapeutic treatment. Show more